PT959072E - Derivado sulfonamida e processo para a preparacao do mesmo - Google Patents
Derivado sulfonamida e processo para a preparacao do mesmoInfo
- Publication number
- PT959072E PT959072E PT99110998T PT99110998T PT959072E PT 959072 E PT959072 E PT 959072E PT 99110998 T PT99110998 T PT 99110998T PT 99110998 T PT99110998 T PT 99110998T PT 959072 E PT959072 E PT 959072E
- Authority
- PT
- Portugal
- Prior art keywords
- substituted
- unsubstituted
- sub
- hypertension
- sup
- Prior art date
Links
- 229940124530 sulfonamide Drugs 0.000 title abstract 2
- 150000003456 sulfonamides Chemical class 0.000 title abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 206010007558 Cardiac failure chronic Diseases 0.000 abstract 1
- 102000002045 Endothelin Human genes 0.000 abstract 1
- 108050009340 Endothelin Proteins 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- -1 R<sup>1</sup> is H Chemical group 0.000 abstract 1
- 208000003782 Raynaud disease Diseases 0.000 abstract 1
- 208000012322 Raynaud phenomenon Diseases 0.000 abstract 1
- 208000007107 Stomach Ulcer Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 abstract 1
- 201000005917 gastric ulcer Diseases 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 208000002815 pulmonary hypertension Diseases 0.000 abstract 1
- 206010038464 renal hypertension Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7116213A JP3013752B2 (ja) | 1995-05-16 | 1995-05-16 | スルホンアミド誘導体 |
| JP14987295 | 1995-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT959072E true PT959072E (pt) | 2002-12-31 |
Family
ID=26454593
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99110998T PT959072E (pt) | 1995-05-16 | 1996-05-14 | Derivado sulfonamida e processo para a preparacao do mesmo |
| PT96107694T PT743307E (pt) | 1995-05-16 | 1996-05-14 | Derivadosulfonamida e processo para a preparacao do mesmo |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT96107694T PT743307E (pt) | 1995-05-16 | 1996-05-14 | Derivadosulfonamida e processo para a preparacao do mesmo |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5739333A (pt) |
| EP (3) | EP0959073A1 (pt) |
| KR (1) | KR100411358B1 (pt) |
| CN (1) | CN1100043C (pt) |
| AT (2) | ATE205482T1 (pt) |
| CA (1) | CA2176776A1 (pt) |
| DE (2) | DE69624010T2 (pt) |
| DK (2) | DK0743307T3 (pt) |
| ES (2) | ES2184367T3 (pt) |
| GR (1) | GR3036611T3 (pt) |
| MX (2) | MX9601837A (pt) |
| PT (2) | PT959072E (pt) |
| TW (1) | TW350839B (pt) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5739333A (en) * | 1995-05-16 | 1998-04-14 | Tanabe Seiyaku Co., Ltd. | Sulfonamide derivative and process for preparing the same |
| US7045519B2 (en) * | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| US6489344B1 (en) | 1998-06-19 | 2002-12-03 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| CA2315614C (en) | 1999-07-29 | 2004-11-02 | Pfizer Inc. | Pyrazoles |
| CA2361402C (en) * | 1999-09-03 | 2009-05-12 | Actelion Pharmaceuticals Ltd | Bis-sulfonamides |
| US6720322B2 (en) | 1999-12-22 | 2004-04-13 | Actelion Pharamceuticals Ltd. | Butyne diol derivatives |
| BR0016241A (pt) * | 1999-12-22 | 2002-11-12 | Actelion Pharmaceuticals Ltd | Compostos, composições farmacêuticas, uso de um ou mais compostos, e, processo para a fabricação de composições farmacêuticas |
| KR100495550B1 (ko) * | 2000-01-25 | 2005-06-16 | 에프. 호프만-라 로슈 아게 | 설폰아미드의 제조 방법 |
| US6387915B2 (en) | 2000-05-31 | 2002-05-14 | Pfizer Inc. | Isoxazole-sulfonamide endothelin antagonists |
| ES2246330T3 (es) * | 2000-06-13 | 2006-02-16 | Basf Aktiengesellschaft | 2-(cianoamino)pirimidinas 5-fenil-sustituidas fungicidas. |
| MY140724A (en) | 2000-07-21 | 2010-01-15 | Actelion Pharmaceuticals Ltd | Novel arylethene-sulfonamides |
| US6670362B2 (en) | 2000-09-20 | 2003-12-30 | Pfizer Inc. | Pyridazine endothelin antagonists |
| US7091201B2 (en) * | 2000-09-25 | 2006-08-15 | Actelion Pharmaceuticals Ltd. | Arylalkane-sulfonamides having endothelin-antagonist activity |
| HU229403B1 (en) | 2000-12-18 | 2013-12-30 | Actelion Pharmaceuticals Ltd | Novel sulfamides and their use as endothelin receptor antagonists |
| SK11422003A3 (sk) * | 2001-03-15 | 2004-04-06 | Basf Aktiengesellschaft | 5-Fenylpyrimidíny, spôsoby a medziprodukty na ich prípravu a ich použitie pri ničení škodlivých húb |
| DE60224223T2 (de) * | 2002-01-02 | 2008-12-04 | Actelion Pharmaceuticals Ltd. | Neue alkylsulfonamide als endothelinantagonisten |
| EP1507756B1 (en) * | 2002-05-24 | 2015-07-22 | Millennium Pharmaceuticals, Inc. | Ccr9 inhibitors and methods of use thereof |
| WO2004050640A1 (en) | 2002-12-02 | 2004-06-17 | Actelion Pharmaceuticals Ltd | Pyrimidine-sulfamides and their use as endothelian receptor antagonist |
| PT1725540E (pt) | 2004-03-05 | 2012-11-29 | Hoffmann La Roche | Diaminopirimidinas como antagonistas de p2x3 e p2x2/3 |
| DE102004044829A1 (de) * | 2004-09-16 | 2006-04-06 | Bayer Cropscience Ag | 5-Heterocyclylpyrimidine |
| TW200628467A (en) | 2004-11-11 | 2006-08-16 | Actelion Pharmaceuticals Ltd | Novel sulfamides |
| EP1924565B1 (en) | 2005-09-01 | 2016-09-14 | F.Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p3x2/3 modulators |
| CA2620129C (en) | 2005-09-01 | 2014-12-23 | F. Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| JP4850911B2 (ja) | 2005-09-01 | 2012-01-11 | エフ．ホフマン−ラ ロシュ アーゲー | Ｐ２ｘ３およびｐ２ｘ２／３モジュレーターとしてのジアミノピリミジン |
| KR20080111137A (ko) * | 2006-04-13 | 2008-12-22 | 액테리온 파마슈티칼 리미티드 | 초기 단계 특발성 폐 섬유증을 위한 엔도텔린 수용체 대항제 |
| AR062501A1 (es) | 2006-08-29 | 2008-11-12 | Actelion Pharmaceuticals Ltd | Composiciones terapeuticas |
| US8664390B2 (en) * | 2007-06-29 | 2014-03-04 | Generics (Uk) Limited | Process for the introduction of hydroxyethoxy side chain in bosentan |
| MX2010001837A (es) | 2007-08-17 | 2010-03-10 | Actelion Pharmaceuticals Ltd | Derivados de 4-pirimidinasulfamida. |
| JP2011500780A (ja) * | 2007-10-24 | 2011-01-06 | ジェネリクス・（ユーケー）・リミテッド | 新規結晶形 |
| EP2072503B1 (en) * | 2007-12-18 | 2011-10-26 | Dipharma Francis S.r.l. | Process for the preparation of bosentan |
| PT2245018T (pt) * | 2008-02-08 | 2017-12-05 | Generics Uk Ltd | Processo para preparar bosentano |
| EP2268634A2 (en) * | 2008-03-13 | 2011-01-05 | Actavis Group PTC EHF | Processes for the preparation of bosentan and related compounds using novel intermediates |
| EP2350028A1 (en) | 2008-11-03 | 2011-08-03 | Generics [UK] Limited | Hplc method for the analysis of bosentan and related substances and use of these substances as reference standards and markers |
| WO2012056468A1 (en) * | 2010-10-13 | 2012-05-03 | Matrix Laboratories Ltd | A process for the preparation of bosentan |
| CN104892528A (zh) * | 2014-12-10 | 2015-09-09 | 上海工程技术大学 | 一种2-硫代巴比妥酸衍生物的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1545944A1 (de) * | 1964-06-19 | 1969-12-11 | Hoffmann La Roche | Verfahren zur Herstellung von neuen Sulfonamiden der Pyrimidinreihe |
| EP0100189B1 (en) * | 1982-07-22 | 1986-05-28 | Pfizer Limited | Dihydropyridine anti-ischaemic and antihypertensive agents |
| KR920009574B1 (ko) * | 1990-02-02 | 1992-10-19 | 재단법인 한국화학연구소 | 페닐아세트아미드 유도체 및 그의 제조방법 |
| TW270116B (pt) * | 1991-04-25 | 1996-02-11 | Hoffmann La Roche | |
| RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
| NZ247440A (en) * | 1992-05-06 | 1995-04-27 | Squibb & Sons Inc | Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof |
| TW287160B (pt) * | 1992-12-10 | 1996-10-01 | Hoffmann La Roche | |
| TW394761B (en) * | 1993-06-28 | 2000-06-21 | Hoffmann La Roche | Novel Sulfonylamino Pyrimidines |
| IL111959A (en) * | 1993-12-17 | 2000-07-16 | Tanabe Seiyaku Co | N-(polysubstituted pyrimidin-4-yl) benzenesulfonamide derivatives their preparation and pharmaceutical compositions containing them |
| US5739333A (en) * | 1995-05-16 | 1998-04-14 | Tanabe Seiyaku Co., Ltd. | Sulfonamide derivative and process for preparing the same |
| DE03078129T1 (de) * | 1996-06-28 | 2004-09-30 | Ranpak Corp., Concord Township | Polsterumwandlungsmaschine |
-
1996
- 1996-05-09 US US08/644,847 patent/US5739333A/en not_active Expired - Fee Related
- 1996-05-14 DE DE69624010T patent/DE69624010T2/de not_active Expired - Fee Related
- 1996-05-14 PT PT99110998T patent/PT959072E/pt unknown
- 1996-05-14 AT AT96107694T patent/ATE205482T1/de not_active IP Right Cessation
- 1996-05-14 ES ES99110998T patent/ES2184367T3/es not_active Expired - Lifetime
- 1996-05-14 EP EP99110999A patent/EP0959073A1/en not_active Withdrawn
- 1996-05-14 DE DE69615085T patent/DE69615085T2/de not_active Expired - Fee Related
- 1996-05-14 EP EP96107694A patent/EP0743307B1/en not_active Expired - Lifetime
- 1996-05-14 DK DK96107694T patent/DK0743307T3/da active
- 1996-05-14 AT AT99110998T patent/ATE224879T1/de not_active IP Right Cessation
- 1996-05-14 ES ES96107694T patent/ES2163548T3/es not_active Expired - Lifetime
- 1996-05-14 PT PT96107694T patent/PT743307E/pt unknown
- 1996-05-14 DK DK99110998T patent/DK0959072T3/da active
- 1996-05-14 EP EP99110998A patent/EP0959072B1/en not_active Expired - Lifetime
- 1996-05-15 MX MX9601837A patent/MX9601837A/es not_active IP Right Cessation
- 1996-05-16 KR KR1019960016486A patent/KR100411358B1/ko not_active IP Right Cessation
- 1996-05-16 CN CN96106284A patent/CN1100043C/zh not_active Expired - Fee Related
- 1996-05-16 CA CA002176776A patent/CA2176776A1/en not_active Abandoned
- 1996-05-22 TW TW085106047A patent/TW350839B/zh active
-
2000
- 2000-11-10 MX MXPA00011111A patent/MXPA00011111A/es unknown
-
2001
- 2001-09-13 GR GR20010400308T patent/GR3036611T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE224879T1 (de) | 2002-10-15 |
| DE69624010D1 (de) | 2002-10-31 |
| DK0743307T3 (da) | 2001-11-26 |
| TW350839B (en) | 1999-01-21 |
| MX9601837A (es) | 1997-07-31 |
| CN1100043C (zh) | 2003-01-29 |
| DE69615085D1 (de) | 2001-10-18 |
| EP0959072B1 (en) | 2002-09-25 |
| EP0959072A1 (en) | 1999-11-24 |
| ES2184367T3 (es) | 2003-04-01 |
| ES2163548T3 (es) | 2002-02-01 |
| MXPA00011111A (es) | 2003-04-25 |
| CA2176776A1 (en) | 1996-11-17 |
| DK0959072T3 (da) | 2003-01-20 |
| KR960041179A (ko) | 1996-12-19 |
| DE69615085T2 (de) | 2002-06-06 |
| CN1146990A (zh) | 1997-04-09 |
| US5739333A (en) | 1998-04-14 |
| ATE205482T1 (de) | 2001-09-15 |
| EP0743307B1 (en) | 2001-09-12 |
| GR3036611T3 (en) | 2001-12-31 |
| EP0959073A1 (en) | 1999-11-24 |
| KR100411358B1 (ko) | 2004-07-05 |
| EP0743307A1 (en) | 1996-11-20 |
| DE69624010T2 (de) | 2003-05-22 |
| PT743307E (pt) | 2001-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT959072E (pt) | Derivado sulfonamida e processo para a preparacao do mesmo | |
| BR9811482A (pt) | Derivados de 1-(n-fenilaminoalquil)-piperazina substituìda na posição 2 do anel fenìlico | |
| EA200200873A1 (ru) | Новые пиперазиновые производные | |
| DK0889876T3 (da) | Meta-substituerede phenylensulfonamidderivater | |
| NZ331546A (en) | 4-phenylamino pyridopyrimidine derivatives, medicaments containing these compounds, their use and process for their production | |
| DE69835430D1 (de) | Sulfonamidderivate, ihre herstellung und verwendung | |
| WO1999024022A3 (en) | Isoquinoline derivatives for treating disorders associated with 5ht7 receptors | |
| NO20013369L (no) | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon | |
| DE3587148D1 (de) | Indolsaeureverbindungen und ihre anwendung als antiallergische heilmittel. | |
| UY25230A1 (es) | Derivados de la d-prolina | |
| MX9605128A (es) | Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos. | |
| ATE252575T1 (de) | Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung | |
| PT729455E (pt) | Arilpiperazinas derivadas de indol como ligados para os receptores 5ht1-like, 5ht1b e 5ht1d | |
| BR9507929A (pt) | Composto de 4-aril-1-(inano-metil di-hidro-benzo-furano- metil ou di-hidro-benzo-tiofeno-metil) -piperidina -terra-hidro- piridina ou -piperazina composiç o farmacêutica e uso do composto | |
| ATE266017T1 (de) | Radicicolderivate | |
| MX9300552A (es) | Derivados de etanolamina | |
| EP1020452A4 (en) | benzimidazole derivatives | |
| IE870128L (en) | Dihydrobenzofuran and chroman - carboxamides | |
| ES507994A0 (es) | Un procedimiento para la preparacion de un compuesto de quinazolina. | |
| BR0114367A (pt) | Processo para a preparação de um composto, e, composto | |
| FI970785A (fi) | Fuusioituneet indoli- ja kinoksaliinijohdannaiset ja niiden valmistus ja käyttö | |
| SE9704272D0 (sv) | Novel Compounds | |
| BR9812431A (pt) | Alguns antagonistas de endotelina de dióxido de benzotiazina e processos para sua preparação | |
| DE60002292D1 (de) | (3,4-dihydro-2h-benzo[1,4]oxazinyl-methyl)-3-(1h-indol-3-yl)-alkylamine | |
| DK0701551T3 (da) | 3-(Indol-3-yl)propensyrederivater som NMDA-antagonister |